NEW YORK, Sept 29 - SEQUENOM (Nasdaq: SQNM) said Friday it had sold four of its MassArray systems for SNP analysis, bringing the company’s installed commercial base of systems to 16.

Sequenom sold the systems to Hitachi (NYSE: HIT), Genetics Institute, Genaissance Pharmaceuticals (Nasdaq: GNSC) and Integrated DNA Technologies. It did not disclose the terms of the deals.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.